News

Hims & Hers to bring generic semaglutide to Canada
The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug ...
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...
GLP-1 maker jumps on patent lapse
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
U.S. telehealth upstart plans to sell generic Ozempic in Canada as patent due to lapse
U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...
Hims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy
Hims & Hers Health (NYSE:HIMS) stock gains as the company eyes Canada expansion to offer affordable versions of Novo ...
NBC Washington3d
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.